Clinical trial
Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct…
NCT00453076 · Asan Medical Center, Other · Completed
Key facts
| NCT number | NCT00453076 |
|---|---|
| Title | Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct Obstruction |
| Official title | Randomized Trial of Conventional Covered Self Expandable Metallic Stent Versus Paclitaxel Eluting Covered Self Expandable Metallic Stent in Unresectable Malignant Bile Duct Obstruction |
| Lead sponsor | Asan Medical Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bile Duct Obstruction |
| Intervention type | Device |
| Interventions | Paclitaxel eluting covered metal stent and control covered metal stent |
| Enrollment | 52 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Mar 28, 2007 |
| Last update posted | Jun 11, 2010 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: